129 related articles for article (PubMed ID: 16971704)
1. Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide.
Odegard PS; Setter SM; Iltz JL
Diabetes Educ; 2006; 32(5):693-712. PubMed ID: 16971704
[TBL] [Abstract][Full Text] [Related]
2. Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus.
Hoogwerf BJ
Cleve Clin J Med; 2006 May; 73(5):477-84. PubMed ID: 16708716
[TBL] [Abstract][Full Text] [Related]
3. Therapies for diabetes: pramlintide and exenatide.
Jones MC
Am Fam Physician; 2007 Jun; 75(12):1831-5. PubMed ID: 17619527
[TBL] [Abstract][Full Text] [Related]
4. Exenatide and pramlintide: new therapies for diabetes.
Want LL; Ratner R
Int J Clin Pract; 2006 Dec; 60(12):1522-3. PubMed ID: 17109659
[No Abstract] [Full Text] [Related]
5. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
Singh-Franco D; Robles G; Gazze D
Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
[TBL] [Abstract][Full Text] [Related]
6. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
Baron AD; Kim D; Weyer C
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
[TBL] [Abstract][Full Text] [Related]
7. [Exenatide--an incretin-mimetic agent for the treatment of type 2 diabetes mellitus].
Reuter H; Erdmann E
Dtsch Med Wochenschr; 2007 Mar; 132(11):571-4. PubMed ID: 17342635
[TBL] [Abstract][Full Text] [Related]
8. New potential adjuncts to treatment of children with type 1 diabetes mellitus.
Raman VS; Heptulla RA
Pediatr Res; 2009 Apr; 65(4):370-4. PubMed ID: 19092720
[TBL] [Abstract][Full Text] [Related]
9. Diabetes basics. Exenatide and pramlintide. New meds on the block.
Griffin S; Borders J
Diabetes Self Manag; 2006; 23(4):74-6, 79. PubMed ID: 16888865
[No Abstract] [Full Text] [Related]
10. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Ryan GJ; Jobe LJ; Martin R
Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options in development for management of diabetes: pharmacologic agents and new technologies.
Lebovitz HE
Endocr Pract; 2006; 12 Suppl 1():142-7. PubMed ID: 16627399
[TBL] [Abstract][Full Text] [Related]
12. Exenatide: its position in the treatment of type 2 diabetes.
Guerci B; Martin CS
Ann Endocrinol (Paris); 2008 Jun; 69(3):201-9. PubMed ID: 18533126
[TBL] [Abstract][Full Text] [Related]
13. An update on exenatide, a novel therapeutic option for patients with type 2 diabetes.
Crasto W; Khunti K; Davies MJ
Drugs Today (Barc); 2011 Nov; 47(11):839-56. PubMed ID: 22146227
[TBL] [Abstract][Full Text] [Related]
14. Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).
BioDrugs; 2003; 17(1):73-9. PubMed ID: 12534323
[TBL] [Abstract][Full Text] [Related]
15. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
Sheffield CA; Kane MP; Busch RS
Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
[TBL] [Abstract][Full Text] [Related]
16. [New drugs; exenatide and sitagliptin].
van Bronswijk H; Dubois EA; Pijl H; Cohen AF
Ned Tijdschr Geneeskd; 2008 Apr; 152(15):876-9. PubMed ID: 18512528
[TBL] [Abstract][Full Text] [Related]
17. Pramlintide for the treatment of diabetes mellitus.
Kleppinger EL; Vivian EM
Ann Pharmacother; 2003; 37(7-8):1082-9. PubMed ID: 12841822
[TBL] [Abstract][Full Text] [Related]
18. [Insulin secretion is increased depending on glucose.. Metabolism regulation in type 2 diabetes mellitus over five paths].
MMW Fortschr Med; 2009 May; 151(19):50. PubMed ID: 19827447
[No Abstract] [Full Text] [Related]
19. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
[TBL] [Abstract][Full Text] [Related]
20. Exenatide: AC 2993, AC002993, AC2993A, exendin 4, LY2148568.
Drugs R D; 2004; 5(1):35-40. PubMed ID: 14725490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
